These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8845267)

  • 21. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department.
    Mitchell AM; Kline JA
    J Thromb Haemost; 2007 Jan; 5(1):50-4. PubMed ID: 17026644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ
    Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
    El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
    Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction.
    Avci E; Yeşil M; Bayata S; Postaci N; Arikan E; Cirit M
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):613-7. PubMed ID: 21959875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.
    Petek BJ; Bravo PE; Kim F; de Boer IH; Kudenchuk PJ; Shuman WP; Gunn ML; Carlbom DJ; Gill EA; Maynard C; Branch KR
    Ann Emerg Med; 2016 Apr; 67(4):469-476.e1. PubMed ID: 26363571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiocontrast-associated renal dysfunction: incidence and risk factors.
    Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG; Sprayregen S
    AJR Am J Roentgenol; 1991 Jul; 157(1):49-58. PubMed ID: 2048539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing the delay in thrombolysis: is it necessary to await the results of renal function tests before computed tomography perfusion and angiography in patients with code stroke?
    Mehdiratta M; Schlaug G; Kumar S; Caplan LR; Selim M
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):273-5. PubMed ID: 18755406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging.
    Josephson SA; Dillon WP; Smith WS
    Neurology; 2005 May; 64(10):1805-6. PubMed ID: 15911820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-modal CT in acute stroke: wait for a serum creatinine before giving intravenous contrast? No!
    Ang TE; Bivard A; Levi C; Ma H; Hsu CY; Campbell B; Donnan G; Davis SM; Parsons M
    Int J Stroke; 2015 Oct; 10(7):1014-7. PubMed ID: 26306403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography.
    Ariyoshi S; Tanabe M; Ito K
    Eur J Radiol; 2020 Nov; 132():109335. PubMed ID: 33164788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cortical retention of contrast medium after angiography as assessed by delayed CT: a multivariate analysis.
    Yamazaki H; Oi H; Matsushita M; Inoue T; Murayama S; Koizumi M; Nose T; Tanaka E; Teshima T; Kagawa K; Inoue T
    Radiat Med; 1996; 14(5):247-50. PubMed ID: 8988503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
    Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.